Sorted By:

Relevance


Medicare Monday: Provider consolidation drives up costs for patients and government

PhRMA  |  Blog Post

A study conducted by Milliman for the Community Oncology Alliance, released earlier this month, found from 2004 to 2014 spending on chemotherapy infusions shifted from less expensive physician offices to more expensive hospital outpatient facilities, resulting in a rise in per-patient-per-year costs.
http://catalyst.phrma.org/medicare-monday-provider-consolidation-drives-up-costs-for-patients-and-government

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Healthy Outlook: Nicole Sweeney of Boston Healthcare Associates contributed a guest post this week highlighting their new white paper, “The Value of Innovation in Oncology: Recognizing Emerging Benefits Over Time.”
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-may-29-2015

PhRMA Careers: Director, Rx Response (Programming)

PhRMA  |  PhRMA Career

Please check our careers page for more opportunities. 
https://www.phrma.org/careers/phrma-careers-director-rx-response-programming

Terms of Service

PhRMA  |  From PhRMA

Privacy: Your use of the Service will be governed by our Privacy Policy.
https://www.phrma.org/terms-of-service

TPP's Outcome Pivotal For Future Of Global Biomedical Innovation

From Hope To Cures  |  From Our Network

For instance, a Canadian study on the impact of pharmaceutical innovation on premature cancer mortality finds pharmaceutical innovation has saved more than 100,000 years of aggregate life.
http://www.fromhopetocures.org/tpp-s-outcome-pivotal-for-future-of-global-biomedical-innovation

Health coverage resources in Spanish

PhRMA  |  Blog Post

Lists of questions to ask and consider when looking for coverage.
http://catalyst.phrma.org/health-coverage-resources-in-spanish

Medicare Monday: Kicking off 2017 with Medicare resources

PhRMA  |  Blog Post

Check out our Part D resources page.
http://catalyst.phrma.org/medicare-monday-kicking-off-2017-with-medicare-resources

Biopharmaceutical Industry Speakers List

PhRMA  |  Report

The Biopharmaceutical Industry Speakers List contains names of executives at the Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies available to participate in events and panel discussions on the cost and value of prescription medicines.
https://www.phrma.org/report/biopharmaceutical-industry-speakers-list

Modern Doctors’ House Calls: Skype Chat And Fast Diagnosis

From Hope To Cures  |  From Our Network

“We are jumping in with both feet on this,” said Peter Adler, president of Molina Healthcare of Washington.
http://www.fromhopetocures.org/modern-doctors-house-calls-skype-chat-and-fast-diagnosis

New medicines are part of the solution to hold down future health care costs

PhRMA  |  Blog Post

Our newly released Costs in Context highlights not only costs and spending data about the United States, but also international data and our policy solutions.
http://catalyst.phrma.org/new-medicines-are-part-of-the-solution-to-hold-down-future-health-care-costs

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Watch the video and stay tuned for more on this landmark program as we prepare to celebrate its 50th birthday later this month!
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-july-17-2015

Medicare Monday: Have you heard of CMMI?

PhRMA  |  Blog Post

This gives the Center power to make broad, far-reaching changes.
http://catalyst.phrma.org/medicare-monday-have-you-heard-of-cmmi

NHE Data: Medicine spending grew just 1.3 percent in 2016

PhRMA  |  Blog Post

All major payers (Medicare, Medicaid and commercial health plans) experienced slower retail medicine spending growth in 2016.
http://catalyst.phrma.org/nhe-data-medicine-spending-grew-just-1.3-percent-in-2016

Patience, Hope and Survival: Progress on the Cancer Front

PhRMA  |  Blog Post

Tomorrow, I will be participating in a national conference that brings diverse stakeholders together to find common solutions, including the public policy and medical innovation environments that are needed to ensure progress continues.
http://catalyst.phrma.org/patience-hope-and-survival-progress-on-the-cancer-front

Health-Insurance Enrollment: What You Need to Know

Access Better Coverage  |  From Our Network

16-page application.
http://www.accessbettercoverage.org/social-news/health-insurance-enrollment-what-you-need-to-know

India’s IP Policies: Still Much Room for Improvement

PhRMA  |  Blog Post

If our two countries can get on the same page and maximize the potential of the U.S.
http://catalyst.phrma.org/indias-ip-policies-still-much-room-for-improvement

10 years of living and managing type 1 diabetes; lessons learned

PhRMA  |  Blog Post

But today, more than 10 years later, the feelings and emotions are opposite to those during the type 1 diabetes diagnosis, and we have found the answers to most of the questions we had.
http://catalyst.phrma.org/10-years-of-living-and-managing-type-1-diabetes-lessons-learned

Research in West Virginia

PhRMA  |  Research In Your Backyard

Clinical trial business is good business for the state’s medical schools and clinical research centers and the medicines being tested are often cutting-edge cell and protein treatments with the poten- tial to be safer and more effective than older chemical compound drugs.
https://www.phrma.org/research-in-your-backyard/research-in-west-virginia

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

PhRMA  |  Blog Post

According to IMS, “payers appear to be limiting overall branded product price growth through the negotiation of discounts and rebates.
http://catalyst.phrma.org/icymi-ims-institute-branded-net-medicine-price-increases-lowest-in-past-five-years

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

The platform can be viewed online here: http://phrma.org/sites/default/files/policy-solutions.pdf.
https://www.phrma.org

Biopharma leads sustained economic growth driven by IP-intensive industries

PhRMA  |  Blog Post

Other IP-intensive industries invest $32,406 in R&D per employee, while manufacturing industries in general only invest $15,520 in R&D per employee.
http://catalyst.phrma.org/biopharma-leads-sustained-economic-growth-driven-by-ip-intensive-industries

PhRMA Principles for Payment and Delivery System Reforms

PhRMA  |  Codes & Guidelines

June 13, 2011 http://www.cancernetwork.com/practice-policy/care-model-future-oncology-...
https://www.phrma.org/codes-and-guidelines/phrma-principles-for-payment-and-delivery-system-reforms

Medicare Monday: What you need to know about the latest Medicare Trustees report

PhRMA  |  Blog Post

Cuts proposed by IPAB would be mandatory, giving the board – or the Secretary of Health and Human Services in the absence of an appointed board – the power to make widespread and largely unchecked changes to Medicare.
http://catalyst.phrma.org/what-you-need-to-know-about-the-latest-medicare-trustees-report

Solutions Architect - IT

PhRMA  |  PhRMA Career

We are committed to supporting our staff and strive to create programs that help our team manage the challenges of balancing a fast paced career with personal goals.
https://www.phrma.org/careers/solutions-architect-it

PhRMA Statement on FDA User Fees

PhRMA  |  Press Release

The PDUFA VI agreement, along with the BsUFA II and the GDUFA II are needed to ensure the best and brightest minds at FDA are able to keep pace with the rapid advance of medicine.”
https://www.phrma.org/press-release/phrma-statement-on-fda-user-fees

You have reviewed the first 425 results out of 1101. Each page contains 25 results. You're on page 17.

prev 13 14 15 16 17 18 next